Characterization of CD44-mediated cancer cell uptake and intracellular distribution of hyaluronan-grafted liposomes

Molecular Pharmaceutics

Volumn 8, Issue 4, 2011, Pages 1233-1246

  Qhattal, Hussaini Syed Sha ^a   Liu, Xinli ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID; LIPOSOME;

ARTICLE; CANCER CELL; CELL TRANSPORT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; ENDOSOME; HUMAN; HUMAN CELL; LIPID RAFT; MOLECULAR WEIGHT; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, CD44; CELL LINE, TUMOR; EXTRACELLULAR MATRIX PROTEINS; FLOW CYTOMETRY; HUMANS; HYALURONIC ACID; LIPOSOMES; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; MOLECULAR WEIGHT;

EID: 79961097211     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp2000428     Document Type: Article

References (68)

1. Brigger, I.; Dubernet, C.; Couvreur, P. Nanoparticles in cancer therapy and diagnosis Adv. Drug Delivery Rev. 2002, 54 (5) 631-51 (Pubitemid 35247520)
2. Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Controlled Release 2000, 65 (1-2) 271-84 (Pubitemid 30122932)
3. Matsumura, Y.; Maeda, H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res. 1986, 46 (12 Part 1) 6387-92 (Pubitemid 17221789)
4. Torchilin, V. P. Recent advances with liposomes as pharmaceutical carriers Nat. Rev. Drug Discovery 2005, 4 (2) 145-60 (Pubitemid 40282557)
5. Allen, T. M. Ligand-targeted therapeutics in anticancer therapy Nat. Rev. Cancer 2002, 2 (10) 750-63 (Pubitemid 37328910)
6. Ponta, H.; Sherman, L.; Herrlich, P. A. CD44: from adhesion molecules to signalling regulators Nat. Rev. Mol. Cell Biol. 2003, 4 (1) 33-45 (Pubitemid 36077255)
7. Naor, D.; Sionov, R. V.; Ish-Shalom, D. CD44: structure, function, and association with the malignant process Adv. Cancer Res. 1997, 71, 241-319 (Pubitemid 27197761)
8. Visvader, J. E.; Lindeman, G. J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions Nat. Rev. Cancer 2008, 8 (10) 755-68
9. Platt, V. M.; Szoka, F. C., Jr. Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor Mol. Pharmaceutics 2008, 5 (4) 474-86
10. Toole, B. P. Hyaluronan: from extracellular glue to pericellular cue Nat. Rev. Cancer 2004, 4 (7) 528-39 (Pubitemid 38868622)
11. Scott, J. E.; Heatley, F. Hyaluronan forms specific stable tertiary structures in aqueous solution: a 13C NMR study Proc. Natl. Acad. Sci. U.S.A. 1999, 96 (9) 4850-5 (Pubitemid 29214500)
12. Toole, B. P. Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities Clin. Cancer Res. 2009, 15 (24) 7462-7468
13. Maxwell, C. A.; McCarthy, J.; Turley, E. Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions? J. Cell Sci. 2008, 121 (Part 7) 925-32 (Pubitemid 351639411)
14. Zhou, B.; Weigel, J. A.; Saxena, A.; Weigel, P. H. Molecular cloning and functional expression of the rat 175-kDa hyaluronan receptor for endocytosis Mol. Biol. Cell 2002, 13 (8) 2853-68
15. Scheibner, K. A.; Lutz, M. A.; Boodoo, S.; Fenton, M. J.; Powell, J. D.; Horton, M. R. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2 J. Immunol. 2006, 177 (2) 1272-81 (Pubitemid 44036633)
16. Harada, H.; Takahashi, M. CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and -2 J. Biol. Chem. 2007, 282 (8) 5597-607 (Pubitemid 47093756)
17. Noble, P. W. Hyaluronan and its catabolic products in tissue injury and repair Matrix Biol. 2002, 21 (1) 25-9 (Pubitemid 34100819)
18. Gao, F.; Yang, C. X.; Mo, W.; Liu, Y. W.; He, Y. Q. Hyaluronan oligosaccharides are potential stimulators to angiogenesis via RHAMM mediated signal pathway in wound healing Clin. Invest. Med. 2008, 31 (3) E106-16
19. Deed, R.; Rooney, P.; Kumar, P.; Norton, J. D.; Smith, J.; Freemont, A. J.; Kumar, S. Early-response gene signalling is induced by angiogenic oligosaccharides of hyaluronan in endothelial cells. Inhibition by non-angiogenic, high-molecular-weight hyaluronan Int. J. Cancer 1997, 71 (2) 251-6 (Pubitemid 27252999)
20. Bollyky, P. L.; Falk, B. A.; Wu, R. P.; Buckner, J. H.; Wight, T. N.; Nepom, G. T. Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+CD25+ regulatory T cells J. Leukocyte Biol. 2009, 86 (3) 567-72
21. Arnold, F.; Jia, C.; He, C.; Cherry, G. W.; Carbow, B.; Meyer-Ingold, W.; Bader, D.; West, D. C. Hyaluronan, heterogeneity, and healing: the effects of ultrapure hyaluronan of defined molecular size on the repair of full-thickness pig skin wounds Wound Repair Regener. 1995, 3 (3) 299-310
22. Svanovsky, E.; Velebny, V.; Laznickova, A.; Laznicek, M. The effect of molecular weight on the biodistribution of hyaluronic acid radiolabeled with 111In after intravenous administration to rats Eur. J. Drug Metab. Pharmacokinet. 2008, 33 (3) 149-57
23. Hisada, N.; Satsu, H.; Mori, A.; Totsuka, M.; Kamei, J.; Nozawa, T.; Shimizu, M. Low-molecular-weight hyaluronan permeates through human intestinal Caco-2 cell monolayers via the paracellular pathway Biosci., Biotechnol., Biochem. 2008, 72 (4) 1111-4 (Pubitemid 351679373)
24. Wolny, P. M.; Banerji, S.; Gounou, C.; Brisson, A. R.; Day, A. J.; Jackson, D. G.; Richter, R. P. Analysis of CD44-hyaluronan interactions in an artificial membrane system: insights into the distinct binding properties of high and low molecular weight hyaluronan J. Biol. Chem. 2010, 285 (39) 30170-80
25. Yerushalmi, N.; Arad, A.; Margalit, R. Molecular and cellular studies of hyaluronic acid-modified liposomes as bioadhesive carriers for topical drug delivery in wound healing Arch. Biochem. Biophys. 1994, 313 (2) 267-73 (Pubitemid 24292802)
26. Peer, D.; Margalit, R. Loading mitomycin C inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor models Int. J. Cancer 2004, 108 (5) 780-9 (Pubitemid 38076412)
27. Eliaz, R. E.; Szoka, F. C., Jr. Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells Cancer Res. 2001, 61 (6) 2592-601 (Pubitemid 32685844)
28. de Belder, A. N.; Wik, K. O. Preparation and properties of fluorescein-labelled hyaluronate Carbohydr. Res. 1975, 44 (2) 251-7
29. Collis, L.; Hall, C.; Lange, L.; Ziebell, M.; Prestwich, R.; Turley, E. A. Rapid hyaluronan uptake is associated with enhanced motility: implications for an intracellular mode of action FEBS Lett. 1998, 440 (3) 444-9 (Pubitemid 29052331)
30. Song, J. M.; Im, J. H.; Kang, J. H.; Kang, D. J. A simple method for hyaluronic acid quantification in culture broth Carbohydr. Polym. 2009, 78 (3) 633-634
31. Huang, M.; Ma, Z.; Khor, E.; Lim, L. Y. Uptake of FITC-chitosan nanoparticles by A549 cells Pharm. Res. 2002, 19 (10) 1488-94 (Pubitemid 35266553)
32. Huth, U. S.; Schubert, R.; Peschka-Suss, R. Investigating the uptake and intracellular fate of pH-sensitive liposomes by flow cytometry and spectral bio-imaging J. Controlled Release 2006, 110 (3) 490-504 (Pubitemid 43168188)
33. Ivanov, A. I. Pharmacological inhibition of endocytic pathways: is it specific enough to be useful? Methods Mol. Biol. 2008, 440, 15-33
34. Tammi, R.; Rilla, K.; Pienimaki, J. P.; MacCallum, D. K.; Hogg, M.; Luukkonen, M.; Hascall, V. C.; Tammi, M. Hyaluronan enters keratinocytes by a novel endocytic route for catabolism J. Biol. Chem. 2001, 276 (37) 35111-22
35. Lesley, J.; Hascall, V. C.; Tammi, M.; Hyman, R. Hyaluronan binding by cell surface CD44 J. Biol. Chem. 2000, 275 (35) 26967-75
36. English, N. M.; Lesley, J. F.; Hyman, R. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding Cancer Res. 1998, 58 (16) 3736-42 (Pubitemid 28376577)
37. Wang, L. H.; Rothberg, K. G.; Anderson, R. G. Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation J. Cell Biol. 1993, 123 (5) 1107-17 (Pubitemid 23352421)
38. Brown, D. A. Lipid rafts, detergent-resistant membranes, and raft targeting signals Physiology (Bethesda) 2006, 21, 430-9 (Pubitemid 44879252)
39. Simons, K.; Ikonen, E. Functional rafts in cell membranes Nature 1997, 387 (6633) 569-72 (Pubitemid 27248754)
40. Manunta, M.; Tan, P. H.; Sagoo, P.; Kashefi, K.; George, A. J. Gene delivery by dendrimers operates via a cholesterol dependent pathway Nucleic Acids Res. 2004, 32 (9) 2730-9 (Pubitemid 38885944)
41. Boonen, M.; Hamer, I.; Boussac, M.; Delsaute, A. F.; Flamion, B.; Garin, J.; Jadot, M. Intracellular localization of p40, a protein identified in a preparation of lysosomal membranes Biochem. J. 2006, 395 (1) 39-47
42. Yerushalmi, N.; Margalit, R. Hyaluronic acid-modified bioadhesive liposomes as local drug depots: effects of cellular and fluid dynamics on liposome retention at target sites Arch. Biochem. Biophys. 1998, 349 (1) 21-6 (Pubitemid 28368386)
43. Peer, D.; Margalit, R. Tumor-targeted hyaluronan nanoliposomes increase the antitumor activity of liposomal Doxorubicin in syngeneic and human xenograft mouse tumor models Neoplasia 2004, 6 (4) 343-53 (Pubitemid 38924849)
44. Chono, S.; Li, S. D.; Conwell, C. C.; Huang, L. An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor J. Controlled Release 2008, 131 (1) 64-9
45. Peer, D.; Park, E. J.; Morishita, Y.; Carman, C. V.; Shimaoka, M. Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target Science 2008, 319 (5863) 627-30 (Pubitemid 351197066)
46. Esposito, G.; Geninatti Crich, S.; Aime, S. Efficient cellular labeling by CD44 receptor-mediated uptake of cationic liposomes functionalized with hyaluronic acid and loaded with MRI contrast agents ChemMedChem 2008, 3 (12) 1858-62
47. Taetz, S.; Bochot, A.; Surace, C.; Arpicco, S.; Renoir, J. M.; Schaefer, U. F.; Marsaud, V.; Kerdine-Roemer, S.; Lehr, C. M.; Fattal, E. Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells Oligonucleotides 2009, 19 (2) 103-16
48. Surace, C.; Arpicco, S.; Dufay-Wojcicki, A.; Marsaud, V.; Bouclier, C.; Clay, D.; Cattel, L.; Renoir, J. M.; Fattal, E. Lipoplexes targeting the CD44 hyaluronic acid receptor for efficient transfection of breast cancer cells Mol. Pharmaceutics 2009, 6 (4) 1062-73
49. La Gatta, A.; De Rosa, M.; Marzaioli, I.; Busico, T.; Schiraldi, C. A complete hyaluronan hydrodynamic characterization using a size exclusion chromatography-triple detector array system during in vitro enzymatic degradation Anal. Biochem. 2010, 404 (1) 21-9
50. Underhill, C. B.; Toole, B. P. Physical characteristics of hyaluronate binding to the surface of simian virus 40-transformed 3T3 cells J. Biol. Chem. 1980, 255 (10) 4544-9 (Pubitemid 10060734)
51. Culty, M.; Miyake, K.; Kincade, P. W.; Sikorski, E.; Butcher, E. C.; Underhill, C. The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins J. Cell Biol. 1990, 111 (6 Part 1) 2765-74 (Pubitemid 120014557)
52. Samuelsson, C.; Gustafson, S. Studies on the interaction between hyaluronan and a rat colon cancer cell line Glycoconjugate J. 1998, 15 (2) 169-75 (Pubitemid 28260921)
53. Laurent, T. C.; Fraser, J. R.; Pertoft, H.; Smedsrod, B. Binding of hyaluronate and chondroitin sulphate to liver endothelial cells Biochem. J. 1986, 234 (3) 653-8 (Pubitemid 16028391)
54. Coradini, D.; Zorzet, S.; Rossin, R.; Scarlata, I.; Pellizzaro, C.; Turrin, C.; Bello, M.; Cantoni, S.; Speranza, A.; Sava, G.; Mazzi, U.; Perbellini, A. Inhibition of hepatocellular carcinomas in vitro and hepatic metastases in vivo in mice by the histone deacetylase inhibitor HA-But Clin. Cancer Res. 2004, 10 (14) 4822-30 (Pubitemid 38955536)
55. Fraser, J. R.; Dahl, L. B.; Kimpton, W. G.; Cahill, R. N.; Brown, T. J.; Vakakis, N. Elimination and subsequent metabolism of circulating hyaluronic acid in the fetus J. Dev. Physiol. 1989, 11 (4) 235-42 (Pubitemid 19249508)
56. Sugahara, S.; Okuno, S.; Yano, T.; Hamana, H.; Inoue, K. Characteristics of tissue distribution of various polysaccharides as drug carriers: influences of molecular weight and anionic charge on tumor targeting Biol. Pharm. Bull. 2001, 24 (5) 535-43 (Pubitemid 32499482)
57. Čeh, B.; Winterhalter, M.; Frederik, P. M.; Vallner, J. J.; Lasic, D. D. Stealth® liposomes: From theory to product Adv. Drug Delivery Rev. 1997, 24 (2-3) 165-177
58. Allen, T. M.; Hansen, C.; Martin, F.; Redemann, C.; Yau-Young, A. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo Biochim. Biophys. Acta 1991, 1066 (1) 29-36
59. Bhattacharyya, S.; Bhattacharya, R.; Curley, S.; McNiven, M. A.; Mukherjee, P. Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis Proc. Natl. Acad. Sci. U.S.A. 2010, 107 (33) 14541-6
60. Weigel, J. A.; Raymond, R. C.; Weigel, P. H. The hyaluronan receptor for endocytosis (HARE) is not CD44 or CD54 (ICAM-1) Biochem. Biophys. Res. Commun. 2002, 294 (4) 918-22 (Pubitemid 34687204)
61. Weigel, J. A.; Weigel, P. H. Characterization of the recombinant rat 175-kDa hyaluronan receptor for endocytosis (HARE) J. Biol. Chem. 2003, 278 (44) 42802-11 (Pubitemid 37345890)
62. Simons, K.; Gerl, M. J. Revitalizing membrane rafts: new tools and insights Nat. Rev. Mol. Cell Biol. 2010, 11 (10) 688-99
63. Pike, L. J. Rafts defined: a report on the Keystone Symposium on Lipid Rafts and Cell Function J. Lipid Res. 2006, 47 (7) 1597-8 (Pubitemid 44079915)
64. Oliferenko, S.; Paiha, K.; Harder, T.; Gerke, V.; Schwarzler, C.; Schwarz, H.; Beug, H.; Gunthert, U.; Huber, L. A. Analysis of CD44-containing lipid rafts: Recruitment of annexin II and stabilization by the actin cytoskeleton J. Cell Biol. 1999, 146 (4) 843-54 (Pubitemid 29408909)
65. Bourguignon, L. Y.; Singleton, P. A.; Diedrich, F.; Stern, R.; Gilad, E. CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion J. Biol. Chem. 2004, 279 (26) 26991-7007 (Pubitemid 38812535)
66. Lee, J. L.; Wang, M. J.; Sudhir, P. R.; Chen, J. Y. CD44 engagement promotes matrix-derived survival through the CD44-SRC-integrin axis in lipid rafts Mol. Cell. Biol. 2008, 28 (18) 5710-23
67. Murai, T.; Maruyama, Y.; Mio, K.; Nishiyama, H.; Suga, M.; Sato, C. Low cholesterol triggers membrane microdomain-dependent CD44 shedding and suppresses tumor cell migration. J. Biol. Chem. 2010.
68. Singleton, P. A.; Dudek, S. M.; Ma, S. F.; Garcia, J. G. Transactivation of sphingosine 1-phosphate receptors is essential for vascular barrier regulation. Novel role for hyaluronan and CD44 receptor family J. Biol. Chem. 2006, 281 (45) 34381-93 (Pubitemid 46036646)